Gene · 64109
Papers2,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: KMT2A amplification in two adult patients with B-cell acute lymphoblastic leukemia. | Front Oncol | 2026 | 41836231 | PubTator, text mining | PubMed |
| Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis. | ERJ Open Res | 2026 | 41809871 | PubTator, text mining | PubMed |
| Single Nucleotide Polymorphism Microarray Analysis Unveils Copy-Number Abnormalities and Genetic Heterogeneity in Malaysian Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. | Mol Genet Genomic Med | 2026 | 41772825 | PubTator, text mining | PubMed |
| Acute lymphoblastic leukemia: an update on treatment and Brazilian perspective. | Front Oncol | 2026 | 41768259 | PubTator, text mining | PubMed |
| Possible Crosstalk Between Small Intestinal Bacterial Overgrowth (SIBO) and Atopic Manifestations-A Short Overview. | Int J Mol Sci | 2026 | 41752000 | PubTator, text mining | PubMed |
| The Interleukin-7 Receptor Signaling Pathway and Its Perturbation in Immunodeficiency, Autoimmune Disease and Lymphoid Malignancy. | Biomolecules | 2026 | 41750289 | PubTator, text mining | PubMed |
| Chronic kidney disease-associated pruritus: a perspective on skin barrier damage. | Ren Fail | 2026 | 41742460 | PubTator, text mining | PubMed |
| Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia. | Ann Hematol | 2026 | 41739208 | PubTator, text mining | PubMed |
| Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD. | Front Immunol | 2026 | 41727449 | PubTator, text mining | PubMed |
| The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. | Immun Inflamm Dis | 2026 | 41725222 | PubTator, text mining | PubMed |
| Homeostatic maturation programs drive human cDC2s into a tolerogenic state. | Immunity | 2026 | 41713421 | PubTator, text mining | PubMed |
| CRLF2 rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link? | Blood Adv | 2026 | 41707115 | PubTator, text mining | PubMed |
| Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs. | Mol Cancer | 2026 | 41699647 | PubTator, text mining | PubMed |
| Interplay between Genetic Ancestry, Self-reported Race and Ethnicity, and Clinical Factors in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report. | Cancer Epidemiol Biomarkers Prev | 2026 | 41697062 | PubTator, text mining | PubMed |
| A review of treatment strategies for elderly patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia. | Transl Oncol | 2026 | 41690286 | PubTator, text mining | PubMed |
| Genomic characterization and prognostic significance of copy number alterations in Tunisian patients with acute lymphoblastic leukemia. | PLoS One | 2026 | 41632752 | PubTator, text mining | PubMed |
| Chemotherapy-Free Achievement of Minimal Residual Disease in a Jehovah's Witness Patient With Ph-Negative B-ALL. | Am J Case Rep | 2026 | 41619253 | PubTator, text mining | PubMed |
| Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer. | ESMO Open | 2026 | 41604814 | PubTator, text mining | PubMed |
| Precision Medicine for Asthma: Tailored to its Severity and Endotype/Phenotype. | Allergy Asthma Immunol Res | 2026 | 41592537 | PubTator, text mining | PubMed |
| Regulation of osteogenic differentiation of boronized Ti6Al4V/HA composite involving TRIP13-PI3K/Akt signaling pathway. | Biomater Adv | 2026 | 41581318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64109/papers?page=2